Organization: Health Canada
Year: 2020
Month: January
Request Number: A-2018-000950
Request Summary: Any one document that provides the batch number(s) of all REVLIMID used in the comparative studies included in the APO-LENALIDOMIDE abbreviated new drug submission number 218298.
Disposition: All exempted
Number of pages: 0